The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs
Open accessAbstract
Animal models for seizures and epilepsy have played a fundamental role in advancing our understanding of basic mechanisms underlying ictogenesis and epileptogenesis and have been instrumental in the discovery and preclinical development of novel antiepileptic drugs (AEDs). However, there is growing concern that the efficacy of drug treatment of epilepsy has not substantially improved with the introduction of new AEDs, which, at least in part, may be due to the fact that the same simple screening models, i.e., the maximal electroshock seizure (MES) and s.c. pentylenetetrazole (PTZ) seizure tests, have been used as gatekeepers in AED discovery for >6 decades. It has been argued that these old models may identify only drugs that share characteristics with existing drugs, and are unlikely to have an effect on refractory epilepsies. Indeed, accumulating evidence with several novel AEDs, including levetiracetan, has shown that the MES and PTZ models do not identify all potential AEDs but instead may fail to discover compounds that have great potential efficacy but work through mechanisms not tested by these models. Awareness of the limitations of acute seizure models comes at a critical crossroad. Clearly, preclinical strategies of AED discovery and development need a conceptual shift that is moving away from using models that identify therapies for the symptomatic treatment of epilepsy to those that may be useful for identifying therapies that are more effective in the refractory population and that may ultimately lead to an effective cure in susceptible individuals by interfering with the processes underlying epilepsy. To realize this goal, the molecular mechanisms of the next generation of therapies must necessarily evolve to include targets that contribute to epileptogenesis and pharmacoresistance in relevant epilepsy models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Self-citationDrug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Self-citationAntiepileptic Drug Development: II. Anticonvulsant Drug Screening
Krall, R. L., Penry, J. K., White, B. G., Kupferberg, H. J., & Swinyard, E. A. (1978) · Epilepsia · doi:10.1111/j.1528-1157.1978.tb04507.x · Cited by 823
Löscher, W., & Schmidt, D. (1988) · Epilepsy Research · doi:10.1016/0920-1211(88)90054-x · Cited by 806
Self-citationPharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
Barton, M. E., Klein, B. D., Wolf, H. H., & Steve White, H. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00302-3 · Cited by 613
Models of Seizures and Epilepsy
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088554-1.x5000-2 · Cited by 561
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Löscher, W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00073-6 · Cited by 509
Self-citationThe neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
Self-citation
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationNew avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationAnimal models of epilepsy: use and limitations
Kandratavicius, L., Balista, P., Lopes-Aguiar, C., Ruggiero, R., Umeoka, E., Garcia-Cairasco, N., Bueno-Junior, L., & Leite, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50371 · Cited by 467
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, J. H., Heales, S. J. R., Walker, M. C., & Williams, R. S. B. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30408-8 · Cited by 440
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D'Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 372
Löscher, W. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2222-z · Cited by 367
Self-citationPentylenetetrazol (PTZ) Kindling Model of Epilepsy
Dhir, A. (2012) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0937s58 · Cited by 327
Antisense Reduction of Tau in Adult Mice Protects against Seizures
DeVos, S. L., Goncharoff, D. K., Chen, G., Kebodeaux, C. S., Yamada, K., Stewart, F. R., Schuler, D. R., Maloney, S. E., Wozniak, D. F., Rigo, F., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2107-13.2013 · Cited by 311
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 298
Afrikanova, T., Serruys, A.-S. K., Buenafe, O. E. M., Clinckers, R., Smolders, I., de Witte, P. A. M., Crawford, A. D., & Esguerra, C. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054166 · Cited by 279
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 276
Crowdsourcing reproducible seizure forecasting in human and canine epilepsy
Brinkmann, B. H., Wagenaar, J., Abbot, D., Adkins, P., Bosshard, S. C., Chen, M., Tieng, Q. M., He, J., Muñoz-Almaraz, F. J., Botella-Rocamora, P., et al. (2016) · Brain · doi:10.1093/brain/aww045 · Cited by 272
Animal models in epilepsy research: legacies and new directions
Grone, B. P., & Baraban, S. C. (2015) · Nature Neuroscience · doi:10.1038/nn.3934 · Cited by 259
Toward Bioelectronic Medicine—Neuromodulation of Small Peripheral Nerves Using Flexible Neural Clip
Lee, S., Peh, W. Y. X., Wang, J., Yang, F., Ho, J. S., Thakor, N. V., Yen, S., & Lee, C. (2017) · Advanced Science · doi:10.1002/advs.201700149 · Cited by 96
Hernan, A. E., Alexander, A., Jenks, K. R., Barry, J., Lenck-Santini, P.-P., Isaeva, E., Holmes, G. L., & Scott, R. C. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.012 · Cited by 73
“As with many epilepsy models and pharmacological disease models in general, it is difficult to dissociate the effect of the seizure and the drug used to induce the seizures (Loscher, 2011).”
Korotkov, A., Broekaart, D. W. M., Banchaewa, L., Pustjens, B., van Scheppingen, J., Anink, J. J., Baayen, J. C., Idema, S., Gorter, J. A., van Vliet, E. A., et al. (2020) · Glia · doi:10.1002/glia.23700 · Cited by 70
Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
Gernert, M., & Feja, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121134 · Cited by 68
“The kindling model of TLE is well-known to be highly predictive of at least systemic drug efficacy against focal limbic seizures in humans [71].”
BackgroundWang, Y., Ying, X., Chen, L., Liu, Y., Wang, Y., Liang, J., Xu, C., Guo, Y., Wang, S., Hu, W., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0431-9 · Cited by 65
Korotkov, A., Broekaart, D. W. M., van Scheppingen, J., Anink, J. J., Baayen, J. C., Idema, S., Gorter, J. A., Aronica, E., & van Vliet, E. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1245-y · Cited by 60
SLC6 Transporter Folding Diseases and Pharmacochaperoning
Freissmuth, M., Stockner, T., & Sucic, S. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_71 · Cited by 42
Gey, L., Gernert, M., & Löscher, W. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.012 · Cited by 21
“Based on previous experiments with vigabatrin and various other AEDs in different models of seizures or epilepsy (Löscher, 2011), we expected that not all rats would respond to vigabatrin with the same anticonvulsant effect, but that responders and nonresponders would occur.”
Self-citationBloms-Funke, P., Bankstahl, M., Bankstahl, J., Kneip, C., Schröder, W., & Löscher, W. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108884 · Cited by 19
Self-citationPresynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
Metadata
- Authors
- Löscher, W.
- Venue
- Seizure
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 20
- Issue
- 5
- Pages
- 359-368
- ISSN
- 1059-1311 (ISSN-L)
- OpenAlex
- W2017398416
- Cited by
- 932
- References
- 42
- FWCI
- 22.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.